Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 May 18:78:103822.
doi: 10.1016/j.amsu.2022.103822. eCollection 2022 Jun.

Unique clinicopathological characteristic and survival rate of metaplastic breast cancer;a special subtype of breast cancer a 5 year cohort study in single referral centre in North Borneo

Nik Amin Sahid Nik Lah  1 , Gracyvinea Nold Imon  1 , Jerry E S Liew  2 , Nurshuhadah Jaafar  3 , Firdaus Hayati  1 , Siti Zubaidah Sharif  3
Affiliations

Unique clinicopathological characteristic and survival rate of metaplastic breast cancer;a special subtype of breast cancer a 5 year cohort study in single referral centre in North Borneo

Nik Amin Sahid Nik Lah et al. Ann Med Surg (Lond). .

Abstract

Introduction: Metaplastic Breast Cancer (MBC) of the breast is a rare entity of breast cancer, with a very poor prognosis, and whose pathophysiology is still unwell established. Therapeutic management is very heterogeneous due to its incomplete understanding. The aim of this study is to describe the demographic, clinical, and therapeutic characteristics of our MBC patient.

Material and methods: A cross-sectional study was conducted to evaluate the demographic and clinicopathological features of these patients. Data of patients diagnosed with metaplastic breast cancer were retrieved from our breast cancer database in Queen Elizabeth Hospital II from January 2015 to May 2021.

Results: 14 patients were diagnosed with metaplastic breast cancer during this period of study. All of them were female, with the average age of 52 years old. The patients were predominantly Bajau and Kadazan Dusun, each comprising of 35%(n = 5). 57% (n = 8) of patients were postmenopausal. 85% (n = 12) of patients were presented with breast lump of an average largest diameter of 69.23 mm. BIRADS staging of the affected breast revealed that most of the patients were BIRADS 5.57% (n = 8) patients underwent mastectomy, 4 went for either breast conserving surgery of the breast. The most common histopathological type is squamous cell carcinoma, which accounts for 42% (n = 6) of the patients. 71% (n = 10) were pathologically triple negative. 7 patients were pathologically node positive. 35% (n = 5) had lung metastasis, and one of the patients had concurrent lung and liver metastasis.

Conclusion: The prognosis of patients with Metaplastic carcinoma of breast remains poor because most of it detected late and histologically triple negative type. Till date, there is no specific management guideline which warrant a multi institutional studies evaluating role of new therapies such as Anti-PD-1 Therapy in combination with chemotherapy to improve patient outcome.

Keywords: Breast; Carcinoma; Metaplastic; Prognosis.

PubMed Disclaimer

Conflict of interest statement

All authors declare that they have no conflict of interest.

References

    1. Han Y., Wang J., Xu B. Clinicopathological characteristics and prognosis of breast cancer with special histological types: a surveillance, epidemiology, and end results database analysis. Breast. 2020;54:114–120. doi: 10.1016/j.breast.2020.09.006. - DOI - PMC - PubMed
    1. Rakha E.A., Tan P.H., Varga Z., et al. Prognostic factors in metaplastic carcinoma of the breast: a multi-institutional study. Br. J. Cancer. 2015;112(2):283–289. doi: 10.1038/bjc.2014.592. - DOI - PMC - PubMed
    1. Zhang Y., Lv F., Yang Y., et al. Clinicopathological features and prognosis of metaplastic breast carcinoma: experience of a major Chinese cancer center. PLoS One. 2015;10(6):1–13. doi: 10.1371/journal.pone.0131409. - DOI - PMC - PubMed
    1. Schroeder M.C., Rastogi P., Geyer C.E., Miller L.D., Thomas A. Early and locally advanced metaplastic breast cancer: presentation and survival by receptor status in surveillance, epidemiology, and end results (SEER) 2010–2014. Oncol. 2018;23(4):481–488. doi: 10.1634/theoncologist.2017-0398. - DOI - PMC - PubMed
    1. Corso G., Frassoni S., Girardi A., et al. Metaplastic breast cancer: prognostic and therapeutic considerations. J. Surg. Oncol. 2021;123(1):61–70. doi: 10.1002/jso.26248. - DOI - PubMed

LinkOut - more resources